Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;31(10):957-966.
doi: 10.1007/s10654-016-0196-9. Epub 2016 Sep 3.

The limitations of opportunistic epidemiology, pseudopod epidemiology

Affiliations

The limitations of opportunistic epidemiology, pseudopod epidemiology

Lewis H Kuller. Eur J Epidemiol. 2016 Oct.

Abstract

Epidemiology has been remarkably successful in the past in identifying the important agents of disease, the impact of the environment, both physical and social, and interrelationship with host susceptibility (genomics). Many of the advances in improving the health of individuals and populations have been the result of epidemiology studies that have identified the specific "agents" of disease and application of public health and preventive medicine. In recent years, large longitudinal studies have dominated epidemiology research, especially long incubation period chronic diseases. The initial hypotheses in these studies have been expanded by vertical extension studies using newer technologies to measure independent variables, vertical pseudopods, and additional studies of other diseases, horizontal pseudopods, of the original longitudinal study. Host susceptibility, i.e. genomics, has also become a prominent component of these longitudinal studies. The critical question addressed in this paper is whether these "pseudopod" epidemiology approaches have enhanced public health or generated a large number of studies of little impact.

Keywords: Epidemiology; Incubation period; Nutrition; Statistics.

PubMed Disclaimer

Similar articles

Cited by

  • The Rotterdam Study: 2018 update on objectives, design and main results.
    Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, Klaver CCW, Nijsten TEC, Peeters RP, Stricker BH, Tiemeier H, Uitterlinden AG, Vernooij MW, Hofman A. Ikram MA, et al. Eur J Epidemiol. 2017 Sep;32(9):807-850. doi: 10.1007/s10654-017-0321-4. Epub 2017 Oct 24. Eur J Epidemiol. 2017. PMID: 29064009 Free PMC article.
  • A note of thanks and an invitation.
    Hofman A. Hofman A. Eur J Epidemiol. 2018 Dec;33(12):1131-1133. doi: 10.1007/s10654-018-0464-y. Eur J Epidemiol. 2018. PMID: 30519805 No abstract available.

References

    1. Ann Intern Med. 2010 Oct 5;153(7):473-4 - PubMed
    1. Eur J Nutr. 2012 Dec;51(8):917-26 - PubMed
    1. JAMA Oncol. 2016 Sep 1;2(9):1154-61 - PubMed
    1. Am J Clin Nutr. 2009 May;89(5):1620S-1626S - PubMed
    1. Epidemiology. 2012 May;23(3):363-7 - PubMed

LinkOut - more resources